PetLife Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense
PetLife Pharmaceuticals, Inc. reported Share-based Payment Arrangement, Expense of $115.86 thousand for the 6-month period ending 2018-02-28, per its 10-Q filed 2018-07-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2018-07-17
- PetLife Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2018-02-28 was $40.11K, a 97.77% decline year-over-year.
- PetLife Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2017-11-30 was $75.75K, a 99.58% decline year-over-year.
- PetLife Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2017-02-28 was $1.80M.
- PetLife Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2016-11-30 was $18.21M.
- PetLife Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2017 was $21.34M, a 2798.66% increase from fiscal 2016.
- PetLife Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2016 was $736.37K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|
| 2018-02-28 | $40.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-17 | $115.86K 10-Q · filed 2018-07-17 | |
| 2017-11-30 | $75.75K 10-Q · filed 2018-01-22 | ||
| 2017-08-31 | $21.34M 10-K · filed 2017-12-15 | ||
| 2017-02-28 | $1.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-17 | $20.01M 10-Q · filed 2018-07-17 | |
| 2016-11-30 | $18.21M 10-Q · filed 2018-01-22 | ||
| 2016-08-31 | $736.37K 10-K · filed 2017-12-15 |